Consensus Statement: Chromosomal Microarray Is a First-Tier Clinical Diagnostic Test for Individuals with Developmental Disabilities or Congenital Anomalies

Boston Children's Hospital, Harvard University, Emory University, University of Washington, National Institutes of Health, National Human Genome Research Institute, ARUP Laboratories (United States), University of Utah, Wellcome Sanger Institute, National Center for Biotechnology Information, Wessex Regional Genetics Laboratory, Howard Hughes Medical Institute, University of California, San Francisco, Uppsala University, University of British Columbia, Child and Family Research Institute, Johns Hopkins University, Johns Hopkins Medicine, Drexel University, Children's Hospital of Philadelphia, University of Groningen, University Medical Center Groningen, University of Pennsylvania, Philadelphia University, University of California, Santa Cruz, Brigham and Women's Hospital, SickKids Foundation, Hospital for Sick Children, University of Toronto, Triangle, Mayo Clinic in Arizona, University of Chicago, American College of Medical Genetics